Form 4: Delek US Holdings CEO Sells Shares Via 10b5-1 Plan

Delek US Holdings President & CEO Avigal Soreq sold 49,000 shares of common stock through a pre-arranged 10b5-1 plan.

Summary

• Avigal Soreq, President & CEO and Director of Delek US Holdings, Inc. (DK), disposed of a total of 49,000 shares of common stock.
• The transactions occurred on March 3, 2026, and were executed under a Rule 10b5-1 trading plan adopted on December 3, 2025.
• The shares were sold in multiple transactions at weighted average prices ranging from $39.85 to $41.71 per share.
• Specifically, 13,768 shares were sold at a weighted average price of $41.71, 34,332 shares at $40.90, and 1,900 shares at $39.85.
• Following these transactions, Avigal Soreq beneficially owns 251,678 shares of Delek US Holdings common stock.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a slightly negative development. While the 10b5-1 plan mitigates concerns of opportunistic selling, a CEO's significant share disposal can still be interpreted as a lack of strong conviction in the stock's near-term appreciation.

Positives

• The transactions were conducted pursuant to a pre-arranged Rule 10b5-1 plan, indicating the sales were scheduled in advance and not based on new, non-public information.

Negatives

• President & CEO Avigal Soreq disposed of a significant number of shares (49,000) of Delek US Holdings common stock.

Risks

• Insider selling by a key executive, even under a 10b5-1 plan, can be interpreted by the market as a signal of potentially limited upside or a belief that the stock is fully valued, which could lead to negative investor sentiment.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance.

Industry Context

StockSavvy.ai notes that insider selling, even when executed under a pre-arranged 10b5-1 plan, is closely monitored by investors for potential signals about management's perception of the company's future stock performance and valuation within the refining and marketing industry.

Stakeholder Impact

• Shareholders may interpret the insider selling as a negative signal regarding the company's future prospects or stock valuation, potentially leading to decreased investor confidence.

Key Dates

Recommendation

While the sale was pre-planned under a 10b5-1 agreement, mitigating the immediate negative implications of opportunistic selling, a significant disposal by the President & CEO is not a positive catalyst. Investors should hold and monitor future insider activity and company performance, as this transaction does not provide a strong reason to buy or aggressively sell.

Keywords

Delek US Holdings, DK, insider trading, Form 4, stock sale, Avigal Soreq, CEO, Director, 10b5-1 plan